Sanford Simon

Sanford Simon


Research Focus & Metrics

Academic Career Length

50Years (1977-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2002 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
Jyoti JaiswalJyoti Jaiswal
Jyoti Jaiswal
HMHedi Mattoussi
Hedi Mattoussi
JMJ. Matthew Mauro
J. Matthew Mauro
SSSanford Simon
Sanford Simon

29 August 2004 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
EVEvelyn B Voura
Evelyn B Voura
Jyoti JaiswalJyoti Jaiswal
Jyoti Jaiswal
HMHedi Mattoussi
Hedi Mattoussi
SSSanford Simon
Sanford Simon

1 May 1991 in Cell
Verified
Journal Article
Closed access
SSSanford Simon
Sanford Simon
GBGünter Blobel
Günter Blobel

1 September 1985 in Biophysical Journal
Verified
Journal Article
Closed access
SSSanford Simon
Sanford Simon
RLR.R. Llinás
R.R. Llinás

26 February 2005 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
HUH. Tetsuo Uyeda
H. Tetsuo Uyeda
IMIgor L. Medintz
Igor L. Medintz
Jyoti JaiswalJyoti Jaiswal
Jyoti Jaiswal
SSSanford Simon
Sanford Simon
HMHedi Mattoussi
Hedi Mattoussi

28 February 2014 in Science
Verified
Journal Article
Open access
PDF file
JHJoshua N. Honeyman
Joshua N. Honeyman
ESElana P. Simon
Elana P. Simon
NRNicolas Robine
Nicolas Robine
RCRachel Chiaroni-Clarke
Rachel Chiaroni-Clarke
DDDavid G. Darcy
David G. Darcy
SSSanford Simon
Sanford Simon
Oncogenic Suspect Exposed: It can be difficult logistically to study the genomics of rare variants of common cancers. Nevertheless, Honeyman et al. (p. 1010 ) studied fibrolamellar hepatocellular carcinoma (FL-HCC), a rare and poorly understood liver tumor that affects adolescents and young adults and for which there is no effective treatment. FL-HCCs from 15 patients all expressed a chimeric RNA transcript and protein containing sequences from a molecular chaperone fused in frame with sequences from the catalytic domain of protein kinase A. The chimeric protein retained kinase activity in vitro. Such recurrent gene fusions in cancer may signal a role in pathogenesis and provide an opportunity for therapeutic intervention.